Wordt geladen...
Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077
Long-acting injectable PrEP could offer an alternative to daily oral PrEP, improve adherence and protection, if found acceptable, safe and effective. HPTN 077 evaluated injectable cabotegravir safety, tolerability and pharmacokinetics among HIV-uninfected males and females in sequentially-enrolled c...
Bewaard in:
| Gepubliceerd in: | AIDS Behav |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer US
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7423859/ https://ncbi.nlm.nih.gov/pubmed/32052214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10461-020-02808-2 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|